🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to compare the efficacy and safety of Inotuzum...
Status
Completed
Location
Stoke Mandeville Hospital (including Wycombe Hospital)
Start Date
2013-10
Trial ID
NCT01679119
Treatments Being Tested
This protocol is designed to assess the efficacy and safety of inotuzumab o...
Status
Terminated
Location
Facey Medical Group
Start Date
2007-11
Trial ID
NCT00562965
The purpose of this study is to determine whether R-FC is more beneficial t...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2009-10
Trial ID
NCT01303887
Treatments Being Tested
The primary objective of the study is to compare the complete response (CR)...
Status
Completed
Location
Teva Investigational Site 165
Start Date
2009-04-30
Trial ID
NCT00877006
Treatments Being Tested
This study will treat follicular lymphoma patients who have not received pr...
Status
Terminated
Location
Integrated Community Oncology Network
Start Date
2006-10
Trial ID
NCT00384111
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as gemcitabine hydrochloride, c...
Status
Completed
Location
Sussex Cancer Centre at Royal Sussex County Hospital
Start Date
2006-03
Trial ID
NCT00971763
Treatments Being Tested
The purpose of this study is to define an improvement and theassessment of ...
Status
Unknown
Location
Azienda Ospedaliera S. Maria
Start Date
2005-12
Trial ID
NCT00774826
This clinical trial is designed to compare the efficacy and safety of R±CEO...
Status
Unknown
Location
Changzhou No.2 People's Hospital
Start Date
2016-07
Trial ID
NCT03151044
This is a phase 1 trial designed to evaluate safety and tolerability of che...
Status
Completed
Location
Davis Cancer Pavillion and Shands Medical Plaza
Start Date
2010-03
Trial ID
NCT01055496
The clinical efficacy of rituximab, a chimeric monoclonal antibody targeted...
Status
Completed
Location
Sung Yong Oh
Start Date
2010-09
Trial ID
NCT01213095
Treatments Being Tested